title: OK-432 sclerotherapy in head and neck lymphangiomas: long-term follow-up result.
abstract: BACKGROUND
  Nonsurgical treatments, such as sclerotherapy have been attempted for head and neck lymphagiomas. Of the available sclerosing agents, picibanil has shown satisfactory short-term treatment results in many studies, but no study has presented long-term treatment results. Accordingly, in the present study, the authors retrospectively reviewed the long-term treatment results of picibanil sclerotherapy.
  
  
  METHODS
  Fifty-five lymphangioma patients who underwent picibanil sclerotherapy were enrolled. Data about initial and long-term response, recurrence, and excision rate were collected.
  
  
  RESULTS
  Initial response rates were 83.5 percent and long-term response rates were 76.3 percent.
  
  
  CONCLUSIONS
  Initial and the long-term response rate were equally good for lymphangioma.
authors.affiliation: Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul, Korea.
authors.forename: Jae Chul
authors.initials: JC
authors.lastname: Yoo
authors.forename: Youngjin
authors.initials: Y
authors.lastname: Ahn
authors.forename: Yune Syung
authors.initials: YS
authors.lastname: Lim
authors.forename: J Hun
authors.initials: JH
authors.lastname: Hah
authors.forename: Tack-Kyun
authors.initials: TK
authors.lastname: Kwon
authors.forename: Myung-Whun
authors.initials: MW
authors.lastname: Sung
authors.forename: Kwang Hyun
authors.initials: KH
authors.lastname: Kim
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000628:therapy*; D006801:Humans; D007223:Infant; D008202:Lymphangioma / Q000628:therapy*; D008297:Male; D010844:Picibanil / Q000627:therapeutic use*; D012189:Retrospective Studies; D012597:Sclerosing Solutions / Q000627:therapeutic use*; D015911:Sclerotherapy / Q000379:methods*
chemical_list: D012597:Sclerosing Solutions; D010844:Picibanil